ID

39511

Descripción

Prospective Observation of Cardiac Safety With Proteasome Inhibition; ODM derived from: https://clinicaltrials.gov/show/NCT02178579

Link

https://clinicaltrials.gov/show/NCT02178579

Palabras clave

Versiones (1)
  1. 21/1/20 21/1/20 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

21 de enero de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Heart Failure NCT02178579

Inglés

Eligibility Heart Failure NCT02178579

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
relapsed multiple myeloma at any time-point in treatment course and planning to start a proteasome inhibitor-based therapy as part of standard care
Descripción

Recurrent Multiple Myeloma | Proteasome inhibitor Planned | Part of Standard therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1370446
UMLS CUI [2,1]
C1443643
UMLS CUI [2,2]
C1301732
UMLS CUI [3,1]
C1292711
UMLS CUI [3,2]
C2936643
received at least one prior line of therapy for multiple myeloma (induction therapy followed by stem cell transplant and consolidation/maintenance therapy will be considered as one line of therapy)
Descripción

Treatment Course Quantity Multiple Myeloma | Neoadjuvant Therapy | Stem cell transplant | Consolidation therapy | Maintenance therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0750729
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0026764
UMLS CUI [2]
C0600558
UMLS CUI [3]
C1504389
UMLS CUI [4]
C1511484
UMLS CUI [5]
C0677908
males and females ≥ 18 years of age
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
able to provide written informed consent in accordance with federal, local, and institutional guidelines
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
poems syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes)
Descripción

POEMS Syndrome

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085404
known or suspected al amyloidosis, secondary amyloidosis or cardiac amyloidosis
Descripción

Primary amyloidosis | Primary amyloidosis Suspected | Reactive systemic amyloidosis | Reactive systemic amyloidosis Suspected | Cardiac amyloidosis | Cardiac amyloidosis Suspected

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0268381
UMLS CUI [2,1]
C0268381
UMLS CUI [2,2]
C0750491
UMLS CUI [3]
C0221014
UMLS CUI [4,1]
C0221014
UMLS CUI [4,2]
C0750491
UMLS CUI [5]
C0268407
UMLS CUI [6,1]
C0268407
UMLS CUI [6,2]
C0750491
plasma cell leukemia (> 2.0 × 109/l circulating plasma cells by standard differential)
Descripción

Leukemia, Plasma Cell | Circulating Plasma Cell Measurement Differential quality

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023484
UMLS CUI [2,1]
C3811668
UMLS CUI [2,2]
C0242485
UMLS CUI [2,3]
C0443199
waldenström macroglobulinemia
Descripción

Waldenstrom Macroglobulinemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024419
myelodysplastic syndrome
Descripción

MYELODYSPLASTIC SYNDROME

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3463824
history of mi within the last 3 months
Descripción

Myocardial Infarction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027051
symptomatic unstable cardiac arrhythmia requiring treatment in the past 3 months
Descripción

Cardiac Arrhythmia Symptomatic Unstable | Treatment required

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003811
UMLS CUI [1,2]
C0231220
UMLS CUI [1,3]
C0443343
UMLS CUI [2]
C0332121
class 3 or 4 new york heart association heart failure in the past 3 months
Descripción

Heart failure New York Heart Association Classification

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C1275491
any other clinically significant medical disease or condition that, in the investigator's opinion, may interfere with protocol adherence or a subject's ability to give informed consent
Descripción

Disease Interferes with Protocol Compliance | Medical condition Interferes with Protocol Compliance | Disease Interferes with Informed Consent | Medical condition Interferes with Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0525058
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0525058
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C0021430
UMLS CUI [4,1]
C3843040
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0021430
Volver a la parte superior de la página

Similar models

Eligibility Heart Failure NCT02178579

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Recurrent Multiple Myeloma | Proteasome inhibitor Planned | Part of Standard therapy
Item
relapsed multiple myeloma at any time-point in treatment course and planning to start a proteasome inhibitor-based therapy as part of standard care
boolean
C1370446 (UMLS CUI [1])
C1443643 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C1292711 (UMLS CUI [3,1])
C2936643 (UMLS CUI [3,2])
Treatment Course Quantity Multiple Myeloma | Neoadjuvant Therapy | Stem cell transplant | Consolidation therapy | Maintenance therapy
Item
received at least one prior line of therapy for multiple myeloma (induction therapy followed by stem cell transplant and consolidation/maintenance therapy will be considered as one line of therapy)
boolean
C0087111 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0026764 (UMLS CUI [1,4])
C0600558 (UMLS CUI [2])
C1504389 (UMLS CUI [3])
C1511484 (UMLS CUI [4])
C0677908 (UMLS CUI [5])
Age
Item
males and females ≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
able to provide written informed consent in accordance with federal, local, and institutional guidelines
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
POEMS Syndrome
Item
poems syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes)
boolean
C0085404 (UMLS CUI [1])
Primary amyloidosis | Primary amyloidosis Suspected | Reactive systemic amyloidosis | Reactive systemic amyloidosis Suspected | Cardiac amyloidosis | Cardiac amyloidosis Suspected
Item
known or suspected al amyloidosis, secondary amyloidosis or cardiac amyloidosis
boolean
C0268381 (UMLS CUI [1])
C0268381 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0221014 (UMLS CUI [3])
C0221014 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0268407 (UMLS CUI [5])
C0268407 (UMLS CUI [6,1])
C0750491 (UMLS CUI [6,2])
Leukemia, Plasma Cell | Circulating Plasma Cell Measurement Differential quality
Item
plasma cell leukemia (> 2.0 × 109/l circulating plasma cells by standard differential)
boolean
C0023484 (UMLS CUI [1])
C3811668 (UMLS CUI [2,1])
C0242485 (UMLS CUI [2,2])
C0443199 (UMLS CUI [2,3])
Waldenstrom Macroglobulinemia
Item
waldenström macroglobulinemia
boolean
C0024419 (UMLS CUI [1])
MYELODYSPLASTIC SYNDROME
Item
myelodysplastic syndrome
boolean
C3463824 (UMLS CUI [1])
Myocardial Infarction
Item
history of mi within the last 3 months
boolean
C0027051 (UMLS CUI [1])
Cardiac Arrhythmia Symptomatic Unstable | Treatment required
Item
symptomatic unstable cardiac arrhythmia requiring treatment in the past 3 months
boolean
C0003811 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,3])
C0332121 (UMLS CUI [2])
Heart failure New York Heart Association Classification
Item
class 3 or 4 new york heart association heart failure in the past 3 months
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Disease Interferes with Protocol Compliance | Medical condition Interferes with Protocol Compliance | Disease Interferes with Informed Consent | Medical condition Interferes with Informed Consent
Item
any other clinically significant medical disease or condition that, in the investigator's opinion, may interfere with protocol adherence or a subject's ability to give informed consent
boolean
C0012634 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0021430 (UMLS CUI [3,3])
C3843040 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0021430 (UMLS CUI [4,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial